Table 4.
Top 20 mutations ranked by RFECV for AmB on F1 set.
NO. | AdaBoost | DecisionTree | GradientBoosting | SVC_Linear | RandomForest |
---|---|---|---|---|---|
1 | ERG10_R278H* | ERG10_R278H* | ERG10_R278H* | ERG10_R278H* | ERG10_R278H* |
2 | ERG3_D283N | B9J08_003902_G126R | B9J08_003902_G126R | B9J08_003902_G126R | B9J08_003736_N36H |
3 | B9J08_003902_G126R | MRR1_H417L | MRR1_H417L | B9J08_005341_K374R | B9J08_003902_G126R |
4 | TAC1B_S195C | B9J08_000267_Y114D | B9J08_000267_Y114D | B9J08_000267_Y114D | B9J08_005338_V621F |
5 | B9J08_005341_A592D | ERG11_I466M* | ERG11_I466M* | ERG11_I466M* | B9J08_005341_N279H |
6 | B9J08_000962_G41E | ERG11_G459S* | ERG11_G459S* | ERG11_G459S* | CDR1_H771R* |
7 | FKS1_S639Y/S639F | ERG11_K143R | ERG11_K143R | ERG11_K143R | B9J08_000267_Y114D |
8 | FKS1_F219V | ERG11_Y132F | B9J08_004576_L747F | ERG11_Y132F | B9J08_001445_S430N |
9 | FKBP12_S4N* | B9J08_004818_S745P | B9J08_004818_S745P | TAC1B_A651T | ERG11_I466M* |
10 | B9J08_001033_L136F | TAC1B_A651T | B9J08_004818_P67H | PGA7_A18P | ERG11_G459S* |
11 | CDR1_G995S* | PGA7_A18P* | TAC1B_S192N | PGA7_E49D | ERG11_K143R |
12 | CDR1_E709G | TAC1B_F214S | TAC1B_A640V | CDR1_G995S* | TAC1B_A651T |
13 | B9J08_000267_Y114D | TAC1B_S192N | TAC1B_A651T | B9J08_005341_K918R | TAC1B_A657V |
14 | UPC2_E229K | B9J08_001445_L368F | TAC1B_A657V | TAC1B_K247E | PGA7_A18P* |
15 | B9J08_001445_L368F | TAC1B_A15T | PGA7_A18P* | TAC1B_F214S | PGA7_E49D* |
16 | B9J08_001445_V317L | TAC1B_A583S | B9J08_001445_L368F | TAC1B_A657V | B9J08_000166_V641D |
17 | ERG11_I466M* | B9J08_005341_A592D | TAC1B_S195C | B9J08_001033_L136F | ERG11_Y132F |
18 | ERG11_G459S* | PGA7_E49D* | B9J08_000268_I6F | B9J08_003735_E275G | UPC2_E229K |
19 | ERG11_K143R | ERG3_D283N | FKS1_K848R | B9J08_001030_E2Q | TAC1B_S192N |
20 | ERG11_Y132F | UPC2_E229K | ERG11_Y132F | CDR1_H771R* | B9J08_004818_S745P |
Bolded means previously reported mutations.
*Represents drug resistance mutation should be paid special attention to.